Prostate cancer Board decisions

The Veteran withdrew his appeal of the service connection claims for lung cancer and prostate cancer in a May 2023 written statement, leading to the dismissal of the appeal.

The Board has remanded the Veteran's claims for service connection due to incomplete records and a failure to comply with previous remand directives.

The Board has decided to remand the case due to lack of substantial compliance with previous remand directives. The cause of death is being reviewed, and a new medical opinion is needed to determine if service-connected conditions caused or aggravated the Veteran's death.

The Board denied service connection for prostate cancer, finding that the evidence does not support a link between the Veteran's current condition and his in-service exposure to herbicides or other chemicals.

The Veteran's erectile dysfunction was not caused or aggravated by his service-connected type II diabetes, hypertension, or prostate cancer. The evidence does not support a finding that the disability is related to in-service exposure to toxins.

The Veteran's claims for service connection for eye disorder (macular degeneration), liver disease, and prostate disorder have been withdrawn. The claim for service connection for prostate disorder is remanded due to the need for a VA medical opinion.

The Veteran's prostate cancer residuals are granted a rating of 40 percent from September 3, 2013 to March 20, 2014.

The Board has determined that the Veteran's prostate cancer is related to his service, and thus grants service connection for this condition.

The Board has remanded the Veteran's claims for prostate cancer and chronic lymphocytic leukemia due to exposure to herbicide agents, specifically Agent Orange. The RO is required to complete all development in the PACT Act sub-regulatory guidance, including documenting the Veteran's participation in all TERAs and verifying his service in Guam. If exposure to herbicides can be conceded on a presumptive basis under the PACT Act, then a direct service connection opinion is needed for the period prior to August 10, 2022.

The Board has remanded the case due to the need for additional development, including obtaining medical opinions regarding whether the Veteran's cause of death was related to his military service and whether it was caused by improper VA treatment.

The Veteran's prostate cancer residuals are denied for a compensable rating from April 1, 2014 to July 9, 2019. A 20 percent disability rating is granted from June 6, 2016 to June 19, 2018 and a 40 percent disability rating is granted from June 19, 2018 to July 9, 2019.

The Veteran is granted presumptive service connection for residuals of prostate cancer due to exposure in the territorial waters of the Republic of Vietnam during his active duty.

The Veteran's claim for service connection for obstructive sleep apnea has been granted. The issues of entitlement to service connection for a right foot condition, prostate cancer, and reflux esophagitis have been remanded.

The Board denied the Veteran's request for an earlier effective date of April 21, 2016 for his service connection for prostate cancer. The Board found that no informal claim was filed prior to this date and thus could not grant a previous effective date.

The Board has decided to remand the case due to inadequate examination report and the need for a urologist's opinion regarding whether the Veteran's prostate cancer was caused by VA carelessness, negligence, or lack of proper skill.

The Board has determined that the Veteran's prostate cancer, which was the principal cause of his death, is related to presumed exposure to contaminated water at Camp Lejeune. As a result, service connection for the cause of death is granted.

The Board has vacated its previous decision and remanded the cases for further development due to failure to comply with prior remand orders.

The Board has remanded the Veteran's claims for service connection due to his exposure to herbicide agents, including Agent Orange. The claims are being reviewed again to determine if there is sufficient evidence of in-service exposure and causation.

The Board has remanded the claims for further development due to insufficient evidence regarding the appellant's exposure to herbicide agents, asbestos, or PCBs during service. The issues of entitlement to service connection for various disabilities are inextricably intertwined with the issue of exposure.

The Board has decided to remand the case due to incomplete information regarding ionizing radiation exposure and a need for an advisory opinion on prostate cancer service connection.